Literature DB >> 2529113

[Suppressor activity of bone marrow and spleen cells in C57Bl/6 mice during carcinogenesis induced by 7,12-dimethylbenz(a)anthracene].

S A Kusmartsev, V I Ogreba.   

Abstract

The nonspecific suppressor activity of bone marrow cells (BMC) and spleen cells (SC) of C57B1/6 mice was studied at 7,12-dimethylbenz(a)anthracene-induced carcinogenesis. It is established that in the latent period of the tumour development and with its appearance the suppressor activity of BMC decreases, while SC-increases. The activity of the BMC suppressor factor which is determined by the inhibition of proliferation of mastocytoma P-815 cells in vitro did not change significantly.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2529113

Source DB:  PubMed          Journal:  Eksp Onkol        ISSN： 0204-3564


  6 in total

Review 1.  Myeloid suppressor cells and immune modulation in lung cancer.

Authors:  Minu K Srivastava; Åsa Andersson; Li Zhu; Marni Harris-White; Jay M Lee; Steven Dubinett; Sherven Sharma
Journal:  Immunotherapy       Date:  2012-03       Impact factor: 4.196

2.  Novel CCL21-vault nanocapsule intratumoral delivery inhibits lung cancer growth.

Authors:  Upendra K Kar; Minu K Srivastava; Asa Andersson; Felicita Baratelli; Min Huang; Valerie A Kickhoefer; Steven M Dubinett; Leonard H Rome; Sherven Sharma
Journal:  PLoS One       Date:  2011-05-03       Impact factor: 3.240

3.  Myeloid suppressor cell depletion augments antitumor activity in lung cancer.

Authors:  Minu K Srivastava; Li Zhu; Marni Harris-White; Upendra K Kar; Upendra Kar; Min Huang; Ming F Johnson; Jay M Lee; David Elashoff; Robert Strieter; Steven Dubinett; Sherven Sharma
Journal:  PLoS One       Date:  2012-07-16       Impact factor: 3.240

4.  Targeting myeloid-derived suppressor cells augments antitumor activity against lung cancer.

Authors:  Minu K Srivastava; Li Zhu; Marni Harris-White; Min Huang; Maie St John; Jay M Lee; Ravi Salgia; Robert B Cameron; Robert Strieter; Steven Dubinett; Sherven Sharma
Journal:  Immunotargets Ther       Date:  2012-10-01

5.  Plasmodium infection inhibits the expansion and activation of MDSCs and Tregs in the tumor microenvironment in a murine Lewis lung cancer model.

Authors:  Dickson Adah; Yijun Yang; Quan Liu; Kranthi Gadidasu; Zhu Tao; Songlin Yu; Linglin Dai; Xiaofen Li; Siting Zhao; Limei Qin; Li Qin; Xiaoping Chen
Journal:  Cell Commun Signal       Date:  2019-04-12       Impact factor: 5.712

6.  Targeting MDSCs enhance therapeutic vaccination responses against lung cancer.

Authors:  Minu K Srivastava; Steven Dubinett; Sherven Sharma
Journal:  Oncoimmunology       Date:  2012-12-01       Impact factor: 8.110
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.